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Abstract: The intramolecular carbene C–H insertion of α-diazo-α-
(methoxycarbonyl)acetamides leading to β-lactams is effectively 
catalyzed by palladium complexes. It is found that whereas Pd(0)-
catalysts typically produce mixtures of β-lactams together with 
Buchner-type reaction products, the use of Pd(II)-catalysts results in 
highly chemoselective transformations. According to DFT 
calculations, this insertion reaction occurs stepwise and involves an 
unprecedented Pd(II)-promoted Mannich-type reaction through a 
metallacarbene-induced zwitterionic intermediate. 
Introduction 
The transition metal-catalyzed intramolecular carbene C–H 
insertion by decomposition of diazo compounds is a well-
established powerful carbon-carbon bond-forming methodology 
for the construction of carbocyclic and heterocyclic 
frameworks.[1] Many transition metal complexes have been used 
as effective catalysts to generate reactive metallacarbenes 
starting from diazo derivatives.[2] Among them, rhodium(II),[3] 
copper(I),[4] and more recently ruthenium(II) catalyst[5] have 
proven especially useful for the development of highly selective 
carbene C–H insertion methodologies via a variety of reaction 
modes. 
Surprisingly, palladium, though one of the most commonly 
employed metals in homogeneous catalysis, has been scarcely 
applied to promote carbene C–H insertion processes.[6] In this 
context, we recently reported that palladium catalysts are able to 
promote Csp3–H insertion of carbenes derived from α-
diazoesters to form pyrrolidines through intramolecular Csp3–
Csp3 bond formation.[7] We also explored the palladium-
catalyzed carbene C–H insertion of α-diazo-α-
(methoxycarbonyl)acetanilides. We found that when using 
palladium catalysts the C–H insertion of such amides occurs 
selectively into the arylic Csp2–H to give the oxindole.[8] 
The aim of the current work was to explore the palladium-
catalyzed intramolecular carbene insertion of α-diazo-α-
(methoxycarbonyl)acetamides for β-lactam elaboration. The β-
lactam system has attracted considerable attention due to its 
ubiquitous presence in the molecular structure of natural 
products and biologically active compounds.[9] We studied how 
the selectivity of the process[10] is affected by the type of catalyst, 
using two oxidation states of palladium, and the substituents on 
the α-diazoacetamide (Scheme 1). 
 
Scheme 1. Substituent and catalyst effects on Pd-catalyzed reactions of α-
diazoacetamides 
Results and Discussion 
We commenced our investigation by studying the palladium-
catalyzed reactions of N,N-dibenzyl-α-diazoacetamide 1 (Table 
1).[11] 
Treatment of 1 with Pd2(dba)3 in 1,2-dichloroethane at 
reflux for 24 h resulted in 76% conversion to give a 1:1 mixture 
of cycloheptapyrrolone 2 and β-lactam trans-3, together with 
some β-lactam cis-3 and the recovery of significant amounts of 
unreacted starting material (Table 1, entry 1). When the reaction 
was performed in the absence of the palladium catalyst, ca. 40% 
of conversion was observed, giving a 1:0.1:1 mixture of 2, cis-3 
and trans-3, together with the unreacted material (Table 1, entry 
2). The complete consumption of the starting material was 
achieved when reactions were run in refluxing toluene (Table 1, 
entries 3-4). 
On the other hand, the [(IMes)Pd(NQ)]2-catalyzed 
decomposition of 1 in DCE at reflux gave cycloheptapyrrolone 2 
as the major product (55%), together with small amounts of β-
lactams cis-3 and trans-3 (Table 1, entry 5). The complete 
consumption of the starting material and the notably different 
selectivity of the latter reaction compared to the thermal process 
in DCE (Table 1, entry 2) clearly supports the role of 
[(IMes)Pd(NQ)]2 as a catalyst in the decomposition of α-
diazoacetamide 1. 
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Pd(II)-catalysts were also able to promote the carbene 
reactions of 1, which resulted in the major formation of β-lactams 
cis-3 and trans-3 at the expense of the Buchner product 2. 
Thus, the [Pd(allyl)Cl]2-catalyzed decomposition of 1 afforded a 
1:1.4:0.5 mixture of cycloheptapyrrolone 2 and β-lactams cis-3 
and trans-3 (Table 1, entry 7). However, after flash 
chromatography, only 2 (20%) and trans-3 (23%) were isolated 
because β-lactam cis-3 underwent isomerization to the more 
stable trans isomer during the purification process. When using 
(SIPr)Pd(allyl)Cl as the catalyst, products 2 and trans-3 were 
isolated in comparable yields (Table 1, entry 8). Finally, 
Pd(TFA)2 also led to the formation of the β-lactams as the main 
products, although a longer reaction time was required and 




Table 1. Pd-catalyzed cyclisation reactions of α-diazoamide 1[a] 
 
entry catalyst (mol%) solvent 1H NMR ratio[b] yield [%][c] 
1 Pd2(dba)3 (10) DCE 1/2/cis-3/trans-3 (1:1.5:0.15:1.5) --- 
2 --- DCE 1/2/cis-3/trans-3 (1:0.3:0.04:0.3) --- 
3 Pd2(dba)3 (10) toluene 2/cis-3/trans-3 (1:0.1:1) 2 (42), trans-3 (42) 
4 --- toluene 2/cis-3/trans-3 (1:0.25:1) 2 (43), trans-3 (45) 
5 [(IMes)Pd(NQ)]2 (2.5) DCE 2/cis-3/trans-3 (1:0.1:0.2) 2 (55), trans-3 (5) 
6 [(IMes)Pd(NQ)]2 (2.5) CH2Cl2 1 --- 
7 [Pd(allyl)Cl]2 (5) DCE 2/cis-3/trans-3 (1:1.4:0.5) 2 (20), trans-3 (23)
[d] 
8 (SIPr)Pd(allyl)Cl (15) DCE[e] 2/cis-3/trans-3 (1:0.25:1.1) 2 (22), trans-3 (20)[d] 
9 (SIPr)Pd(allyl)Cl (10) DCE[e] 1/2/cis-3/trans-3 (1:1.1:0.3:1.4) --- 
10 Pd(TFA)2 (10) CHCl3
[e] 2/cis-3/trans-3 (1:1.2:1) 2 (15), trans-3 (24)[d] 
[a] Reaction conditions: Catalyst (see table) in the indicated solvent at reflux for 24 h. [b] Ratio determined by 1H NMR (400 MHz) from the reaction mixture. [c] 
Yields refer to products isolated by chromatography. [d] Small amounts (≤10%) of N,N-dibenzyl-α-chloro-α-(methoxycarbonyl)acetamide were also obtained. [e] 
Reaction time: 48 h. Pd2(dba)3 = Tris(dibenzylideneacetone)dipalladium(0). [(IMes)Pd(NQ)]2 = 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene (1,4-
naphthoquinone)palladium(0) dimer. (SIPr)Pd(allyl)Cl = Allyl-chloro-[1,3-bis-(2,6-diisopropylphenyl)-2-imidazolidinylidene]palladium(II). 
 
 
The competition between Csp3–H insertion leading to β-
lactams and intramolecular aromatic cycloaddition to give the 
corresponding cycloheptapyrrolone is also common in reactions 
of α-diazoacetamides catalyzed by Rh(II)[11a] and Ru(II)-
catalysts.[11b,12] According to previous mechanistic studies on 
related Rh(II)-catalyzed transformations, the competitive 
formation of β-lactams and aromatic ring reaction products is 
probably due to the stereoelectronic competition between the 
two conformational isomers of the metallacarbene undergoing 
the intramolecular reactions.[13] A strategy to improve site-
selectivity in the transition metal-catalyzed carbene reactions of 
α-diazoacetamides involves replacing one of the N-substituents 
at the amide moiety with a bulky group,[14] which sterically biases 
the conformational preference around the amide N–C(O) bond 
and makes the metallacarbene reaction at the remaining 
substituent more feasible. 
In search of higher site-selectivity in the palladium-
catalyzed insertion leading to β-lactams, we decided to replace 
one of the benzyl groups in 1 with a tert-butyl substituent. Table 
2 shows the results of the palladium-catalyzed reactions with N-
benzyl-N-tbutyl-α-diazoacetamide 4a.[15] 
When α-diazoamide 4a was decomposed in the presence 
of Pd2(dba)3 (Table 2, entry 1), cycloheptapyrrolone 5a (20%) 
was isolated together with β-lactams cis-6a (9%) and trans-6a 
(42%)[16] On changing the catalyst to [(IMes)Pd(NQ)]2, a slight 
increase in the formation of the Buchner product was observed 
(Table 2, entry 2). To our delight, the more electrophilic 
[Pd(allyl)Cl]2 or (SIPr)Pd(allyl)Cl catalysts exclusively promoted 
the Csp3–H insertion to give the β-lactams, which were isolated 
in good overall yields (Table 2, entries 3-4). 
 






Table 2. Pd-catalyzed cyclisation reactions of α-diazoamide 4a[a] 
 




1 Pd2(dba)3 (10) 26/46/28 5a (20) 
cis-6a (9) 
trans-6a (42) 
2 [(IMes)Pd(NQ)]2 (2.5) 35/40/25 5a (28) 
cis-6a (35) 
trans-6a (23) 
3 [Pd(allyl)Cl]2 (5) 0/47/53 cis-6a (25) 
trans-6a (65) 
4 (SIPr)Pd(allyl)Cl (15) 0/29/71 cis-6a (17) 
trans-6a (59) 
[a] Reaction conditions: Catalyst in DCE at reflux for 24 h. [b] 1H NMR ratio. [c] 
All reactions were performed twice. While the 5a/6a ratio was essentially the 
same in the two runs, the cis/trans ratio was quite different due to the partial 
isomerization of cis β-lactam to the more stable trans isomer during the work-
up. [d] Isolated yields. 
 
The palladium-catalyzed carbene insertion was also 
explored from α-diazoamide 7, which bears the α-methylbenzyl 
substituent at the nitrogen (Table 3). Similarly to the reactions of 
N-benzylamide 4a, when Pd(0)-catalysts were used to promote 
the decomposition of 7 a significant amount of the Buchner 
product 8 was obtained (Table 3, entries 1 and 2). 
 
Table 3. Pd-catalyzed cyclisation reactions of α-diazoamide 7[a] 
 
entry catalyst (mol%) 8/9/10[b] products (%)[c] 
1 Pd2(dba)3 (10) 26/37/37 8
[d] (15) 
9 (18), 10 (24) 
2 [(IMes)Pd(NQ)]2 (2.5) 65/20/15 8[e] (42) 
9 (7), 10 (13) 
3 [Pd(allyl)Cl]2 (5) 0/36/64 9 (23), 10 (47) 
4 (SIPr)Pd(allyl)Cl (15) 0/57/43 9 (24), 10 (18) 
[a] Reaction conditions: Catalyst in DCE at reflux for 24 h. [b] 1H NMR ratio. [c] 
Isolated yields. [d] 1:1.2 mixture of stereoisomers. [e] 1:2.2 mixture of 
stereoisomers. 
 
Interestingly, when the reaction was catalyzed by 
Pd2(dba)3, both 4a and 7 gave a ca. 1:3 Buchner/β-lactam ratio. 
On the contrary, when the reaction of 7 was promoted by the 
sterically encumbered [(IMes)Pd(NQ)]2 catalyst, 
cycloheptapyrrolone 8 was obtained as the major product, 
suggesting that the Pd(0)-catalyzed reaction is highly sensitive 
to the steric hindrance on the reactive Csp3–H bond. At variance, 
similar to the reactions of 4a, the use of Pd(II)-catalysts with 7 
resulted in the chemoselective insertion into the Csp3–H bond 
(Table 3, entries 3 and 4), [Pd(allyl)Cl]2 once again affording the 
best result. 
The studies with α-diazoacetamides 4a and 7 gave us two 
experimental procedures for the insertion reaction based on the 
use of either [Pd(allyl)Cl]2 (Method A) or (SIPr)Pd(allyl)Cl 
(Method B) as the catalyst. To explore how the introduction of 
substituents at the benzylic group might influence the insertion 
process leading to β-lactams, these catalytic systems were 
studied with α-diazoacetamides 4b-m (Scheme 2, see Table S1 
in the SI for additional details). 
 
Scheme 2. Synthesis of β-lactams by Pd(II)-catalyzed cyclisation of α-
diazoamides. [a] Method A: [Pd(allyl)Cl]2 or Method B: (SIPr)Pd(allyl)Cl. 
[b] 
(Method, Isolated yield (%), cis/trans ratio after chromatography).  
The effect of the substituent varied according to its 
electronic nature as well as its position on the aromatic ring. The 
introduction of electron-releasing groups at the benzyl 






substituent led to an increased formation of the 
cycloheptapyrrolone product, especially when using 
(SIPr)Pd(allyl)Cl as the catalyst. The increase was lower when 
the substituent was located at the ortho-position, probably due to 
steric interactions. In contrast, electron-withdrawing groups 
generally diverted the palladacarbene away from the Buchner 
reaction in favor of the Csp3–H insertion. Similar electronic 





Figure 1. Computed reaction profiles for the formation of β-lactams 6a. Relative free energies (∆G298, at 298 K) and bond distances are given in kcal/mol and 
angstroms (Å), respectively 
The examples in Tables 2 and 3, and Scheme 2 confirm 
the generality and functional group tolerance of this novel Pd(II)-
catalyzed insertion. The resulting β-lactams were obtained in 
moderate to good overall yields (44-90%), usually as mixtures of 
cis and trans isomers, in transformations proceeding with high 
site-selectivity. As an exception, the Pd(II)-catalyzed 
decomposition of 4f gave trans-6f in poor yield together with 
major amounts of 4-(dimethylamino)benzaldehyde. It is worth 
noting that no product from the potentially competitive Pd-
catalyzed cross-coupling of the aryl halide with the α-diazoamide 
moiety was observed in the reactions of 4k and 4l, which bear 
an ortho-bromo and ortho-iodo substituent, respectively. 
The above results also confirm the significant impact of the 
electronic nature of the palladium catalyst and ensuing 
electrophilicity of the carbene intermediate in the reaction 
pathway. Thus, whereas benzylic Csp3–H insertion is strongly 
favored over the Buchner reaction when using Pd(II)-catalysts, 
an increased cycloheptapyrrolone product formation is usually 
observed with the more electron-rich Pd(0)-catalysts. 
Interestingly, Rh(II)-catalyzed transformations show opposite 
reactivity trends, in which highly electrophilic Rh(II)-complexes 
favor Buchner reactions over benzylic Csp3–H insertion.[10] 
Our previous work has shown that the mechanism involved 
in palladium-catalyzed insertion reactions[7,8] differs considerably 
from that accepted for Rh(II)-catalyzed transformations. 
Whereas Rh(II)-catalysts typically proceed in a concerted 
process that directly releases the insertion product and metal 
catalyst in a single step,[17] palladium catalysts involve stepwise 
reaction mechanisms initiated by a metal-mediated hydrogen 
migration. To shed light on the reaction mechanism and the 
influence of the Pd(II)-catalyst on the selectivity of the C–H 
insertion described herein, density functional theory (DFT) 
calculations were carried out.[18] To this end, the process 
involving 4a in the presence of the [Pd(allyl)Cl]2 catalyst (see 
Table 2, entry 3) was explored. 






The data in Figure 1, which gathers the computed reaction 
profile starting from the initial Pd(II)-carbene intermediate INT0, 
indicate that the formation of the corresponding β-lactams 6a 
occurs stepwise. Thus, INT0 is first transformed into the 
zwitterionic intermediate INT1[19] in a highly exergonic process 
via the transition state TS1. This step can be viewed as a 1,4-
hydrogen migration that is not directly assisted by the metal, 
therefore resembling the mechanism involved in related Ru(II)-
C–H activation processes previously studied by us.[7b] The 
transformation ends with the formation of the new C–C bond via 
the transition state TS2, again in a strongly exergonic 
transformation that releases the β-lactam with concomitant 
regeneration of the active Pd(II)-catalyst. According to the rather 
similar relative energies computed for the cis/trans transition 
states TS1 and TS2, a ca. 50:50 mixture of cis-6a and trans-6a 
can be expected, which is fully consistent with the experimental 
findings (Table 2, entry 3). 
Finally, we also investigated the reasons for the non-
formation of cycloheptapyrrolone 5a when using these reaction 
conditions (i.e. 4a in the presence of [Pd(allyl)Cl]2). Our 
calculations suggest that the first step of the alternative Buchner 
reaction, which involves a palladium-promoted C–C bond 
formation, is not competitive in view of the much higher 
activation barrier required to reach the corresponding transition 
state TS1’ as compared to TS1-trans (∆∆G≠= 8.5 kcal/mol) as 
well as the endergonicity (∆∆G = +6.0 kcal/mol) associated with 
this step. Therefore, no Buchner reaction product should be 
expected, which agrees nicely with the complete selectivity 
observed experimentally (Table 2, entry 3). 
Conclusions 
In summary, we have shown that palladium can be used to 
promote the carbene Csp3–H insertion of α-diazoacetamides to 
form β-lactams, Pd(II)-catalysts giving the best 
chemoselectivities. DFT calculations suggest that this 
transformation involves an unprecedented Pd(II)-promoted 
Mannich-type reaction through a metallacarbene-induced 
zwitterionic intermediate. 
Experimental Section 
General Methods. All commercially available reagents were used 
without further purification. 1H- and 13C NMR spectra were recorded 
using Me4Si as the internal standard, with a Varian Mercury 400 
instrument. Chemical shifts are reported in ppm downfield (δ) from Me4Si 
for 1H and 13C NMR. TLC was carried out on SiO2 (silica gel 60 F254, 
Merck), and the spots were located with UV light or 1% aqueous KMnO4. 
Flash chromatography was carried out on SiO2 (silica gel 60, SDS, 230-
400 mesh ASTM). Drying of organic extracts during workup of reactions 
was performed over anhydrous Na2SO4. Evaporation of solvents was 
accomplished with a rotatory evaporator. 
Representative Procedure for the Preparation of Diazoacetamides 1, 
4a-m and 7. 
To a solution of dibenzylamine (0.6 mL, 3.04 mmol) and Et3N (0.86 mL, 
6.1 mmol) in CH2Cl2 (18 mL), cooled at 0 °C, was added slowly methyl 
malonyl chloride (0.67 mL, 6.1 mmol). The mixture was stirred at room 
temperature for 24 h. After the reaction was completed, the mixture was 
poured into water and extracted with CH2Cl2. The organic extracts were 
washed with saturated NaHCO3 aqueous solution, dried, filtered and 
concentrated. The residue was purified by chromatography (SiO2, from 
hexanes to hexanes/EtOAc 3:2) to give N,N-dibenzyl-α-
(methoxycarbonyl)acetamide (0.88 g, 97%). 
To a solution of N,N-dibenzyl-α-(methoxycarbonyl)acetamide (678 mg, 
2.28 mmol) and DBU (0.52 mL, 3.43 mmol) in dry acetonitrile (16 mL) 
was added dropwise a solution of p-ABSA (602 mg, 2.5 mmol) in dry 
acetonitrile (6 mL). The mixture was stirred at room temperature 
overnight. The solvent was removed in vacuo and the resulting residue 
was partitioned between CH2Cl2 and 10% NaOH aqueous solution. The 
organic extracts were dried, filtered and concentrated. The residue was 
purified by chromatography (SiO2, from CH2Cl2 to CH2Cl2/MeOH 98:2) to 
give N,N-dibenzyl-α-(methoxycarbonyl)-α-diazoacetamide (1, 554 mg; 
75%). 
N,N-Dibenzyl-α-(methoxycarbonyl)-α-diazoacetamide (1). Brown oil. 
1H NMR (CDCl3, 400 MHz) δ 3.79 (s, 3H), 4.51 (s, 4H), 7.15-7.19 (m, 4H), 
7.25-7.36 (m, 6H). 13C NMR (CDCl3, 100.6 MHz) δ 50.5 (broad signal, 2 
CH2), 52.5 (CH3), 67.0 (C), 127.8 (CH), 127.9 (2 CH), 128.8 (2 CH), 
136.4 (C), 162.4 (C), 163.0 (C). HRMS (ESI-TOF) calcd. for C18H18N3O3: 
324.1343 [M+H]+; found: 324.1347. 
N-Benzyl-N-tert-butyl-α-(methoxycarbonyl)-α-diazoacetamide (4a). 
4a was obtained as a yellow oil that solidified on refrigeration (433 mg) 
following the procedures described above [(a) ClCOCH2CO2Me (1 equiv.), 
Et3N (1 equiv.); (b) p-ABSA (1.1 equiv.), DBU (1.5 equiv.), 75% two 
steps]. 1H NMR (CDCl3, 400 MHz) δ 1.39 (s, 9H), 3.77 (s, 3H), 4.62 (s, 
2H), 7.18-7.35 (m, 5H). 13C NMR (CDCl3, 100.6 MHz) δ 28.9 (3 CH3), 
51.7 (CH2), 52.3 (CH3), 59.1 (C), 68.2 (C), 126.9 (2 CH), 127.5 (CH), 
128.8 (2 CH), 139.7 (C), 163.1 (C), 163.2 (C). HRMS (ESI-TOF) calcd. 
for C15H19N3 NaO3: 312.1319 [M+H]
+; found: 312.1327. 
N-tert-Butyl-N-(4-methoxybenzyl)-α-(methoxycarbonyl)-α-
diazoacetamide (4b). 4b was obtained as a yellow oil that solidified on 
refrigeration (600 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1.2 equiv.), Et3N (1.2 equiv.), 61%; (b) p-ABSA (1.1 
equiv.), DBU (1.5 equiv.), 98%]. 1H NMR (CDCl3, 400 MHz) δ 1.36 (s, 
9H), 3.76 (s, 3H), 3.78 (s, 3H), 4.54 (s, 2H), 6.84 (d, J = 8.4 Hz, 2H) 7.09 
(d, J = 8.4 Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.9 (3 CH3), 51.2 
(CH2), 52.3 (CH3), 55.4 (CH3), 59.0 (C), 68.2 (C), 114.1 (2 CH), 128.1 (2 
CH), 131.5 (C), 159.0 (C), 163.1 (C), 163.2 (C). HRMS (ESI-TOF) calcd. 
for C16H21N3 NaO4: 342.1424 [M+H]
+; found: 342.1423. 
N-tert-Butyl-N-[4-(methylthio)benzyl]-α-(methoxycarbonyl)-α-
diazoacetamide (4c). 4c was obtained as a yellow oil that solidified on 
refrigeration (555 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1.2 equiv.), Et3N (1.2 equiv.), 68%; (b) p-ABSA (1.1 
equiv.), DBU (1.5 equiv.), 94%]. 1H NMR (CDCl3, 400 MHz) δ 1.37 (s, 
9H), 2.47 (s, 3H), 3.76 (s, 3H), 4.56 (s, 2H), 7.10 (d, J = 8.0 Hz, 2H) 7.20 
(d, J = 8.0 Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 16.0 (CH3), 28.9 (3 
CH3), 51.3 (CH2), 52.3 (CH3), 59.1 (C), 68.2 (C), 126.9 (2 CH), 127.4 (2 
CH), 136.5 (C), 137.6 (C), 163.0 (C), 163.2 (C). HRMS (ESI-TOF) calcd. 
for C16H22N3O3S: 336.1376 [M+H]
+; found: 336.1378. 
N-tert-Butyl-N-[4-chlorobenzyl]-α-(methoxycarbonyl)-α-
diazoacetamide (4d). 4d was obtained as a yellow oil that solidified on 
refrigeration (514 mg) following the procedures described above [(a) 






ClCOCH2CO2Me (1.3 equiv.), Et3N (1.3 equiv.), 54%; (b) p-ABSA (1.1 
equiv.), DBU (1.5 equiv.), 83%]. 1H NMR (CDCl3, 400 MHz) δ 1.38 (s, 
9H), 3.77 (s, 3H), 4.58 (s, 2H), 7.14 (d, J = 8.4 Hz, 2H) 7.30 (d, J = 8.4 
Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.9 (3 CH3), 51.1 (CH2), 52.4 
(CH3), 59.2 (C), 68.4 (C), 128.3 (2 CH), 129.0 (2 CH), 133.2 (C), 138.3 
(C), 163.0 (C), 163.4 (C). HRMS (ESI-TOF) calcd. for C15H18ClN3NaO3: 
346.0929 [M+H]+; found: 346.0937. 
N-tert-Butyl-N-(4-cyanobenzyl)-α-(methoxycarbonyl)-α-
diazoacetamide (4e). 4e was obtained as a red oil that solidified on 
refrigeration (155 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1.3 equiv.), Et3N (1.3 equiv.), 52%; (b) p-ABSA (1.1 
equiv.), DBU (1.5 equiv.), 33%]. 1H NMR (CDCl3, 400 MHz) δ 1.38 (s, 
9H), 3.77 (s, 3H), 4.67 (s, 2H), 7.33 (d, J = 8.0 Hz, 2H) 7.63 (d, J = 8.0 
Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 29.0 (3 CH3), 51.2 (CH2), 52.4 
(CH3), 59.5 (C), 68.8 (C), 111.5 (C), 118.7 (C), 127.6 (2 CH), 132.6 (2 
CH), 145.7 (C), 162.8 (C), 163.6 (C). HRMS (ESI-TOF) calcd. for 
C16H18N4NaO3: 337.1271 [M+H]
+; found: 337.1279. 
N-tert-Butyl-N-[4-(dimethylamino)benzyl]-α-(methoxycarbonyl)-α-
diazoacetamide (4f). 4f was obtained as a yellow oil that solidified on 
refrigeration (190 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1.3 equiv.), Et3N (1.3 equiv.), 58%; (b) p-ABSA (1.1 
equiv.), DBU (1.5 equiv.), 85%]. 1H NMR (CDCl3, 400 MHz) δ 1.38 (s, 
9H), 2.93 (s, 6H), 3.77 (s, 3H), 4.52 (s, 2H), 6.68 (d, J = 8.8 Hz, 2H), 7.04 
(d, J = 8.8 Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.9 (3 CH3), 40.8 (2 
CH3), 51.3 (CH2), 52.3 (CH3), 58.9 (C), 68.0 (C), 112.7 (2 CH), 126.9 (C), 
127.9 (2 CH), 150.0 (C), 163.0 (C), 163.3 (C). HRMS (ESI-TOF) calcd. 
for C17H25N4O3: 333.1921 [M+H]
+; found: 333.1925. 
N-tert-Butyl-N-(3-chlorobenzyl)-α-(methoxycarbonyl)- α-
diazoacetamide (4g). 4g was obtained as a yellow oil that solidified on 
refrigeration (505 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1.2 equiv.), Et3N (1.2 equiv.), 82%; (b) p-ABSA (1.1 
equiv.), DBU (1.5 equiv.), 85%]. 1H NMR (CDCl3, 400 MHz) δ 1.39 (s, 
9H), 3.77 (s, 3H), 4.59 (s, 2H), 7.09 (d, J = 7.2 Hz, 1H), 7.18 (broad s, 
1H), 7.22-7.29 (m, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 29.0 (3 CH3), 
51.2 (CH2), 52.4 (CH3), 59.3 (C), 68.4 (C), 125.0 (CH), 127.1 (CH), 127.7 
(CH), 130.1 (CH), 134.8 (C), 142.0 (C), 163.0 (C), 163.4 (C). HRMS 
(ESI-TOF) calcd. for C15H18ClN3NaO3: 346.0929 [M+H]
+; found: 346.0933. 
N-tert-Butyl-N-(3-cyanobenzyl)-α-(methoxycarbonyl)- α-
diazoacetamide (4h). 4h was obtained as a yellow oil that solidified on 
refrigeration (330 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1.3 equiv.), Et3N (1.3 equiv.); (b) p-ABSA (1.1 equiv.), 
DBU (1.5 equiv.), 63% two steps]. 1H NMR (CDCl3, 400 MHz) δ 1.38 (s, 
9H), 3.78 (s, 3H), 4.65 (s, 2H), 7.45-7.51 (m, 3H), 7.55-7.59 (m, 1H). 13C 
NMR (CDCl3, 100.6 MHz) δ 29.0 (3 CH3), 51.0 (CH2), 52.4 (CH3), 59.4 
(C), 68.8 (C), 113.0 (C), 118.6 (C), 129.7 (CH), 130.4 (CH), 131.3 (CH), 
131.4 (CH), 141.7 (C), 162.8 (C), 163.6 (C). HRMS (ESI-TOF) calcd. for 
C16H18N4NaO3: 337.1271 [M+H]
+; found: 337.1278. 
N-tert-Butyl-N-(2-methoxybenzyl)-α-(methoxycarbonyl)- α-
diazoacetamide (4i). 4i was obtained as a yellow oil that solidified on 
refrigeration (384 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1 equiv.), Et3N (1 equiv.); (b) p-ABSA (1.1 equiv.), 
DBU (1.5 equiv.), 70% two steps]. 1H NMR (CDCl3, 400 MHz) δ 1.34 (s, 
9H), 3.77 (s, 3H), 3.80 (s, 3H), 4.60 (s, 2H), 6.85 (dd, J = 8.0, and 1.2 Hz, 
1H), 6.92 (td, J = 7.6 and 1.2 Hz, 1H), 7.18 (dd, J = 7.6 and 1.2 Hz, 1H), 
7.25 (ddd, J = 8.0, 7.6 and 1.2 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz) δ 
28.6 (3 CH3), 48.5 (CH2), 52.2 (CH3), 55.6 (CH3), 58.6 (C), 68.0 (C), 
110.7 (CH), 120.5 (CH), 127.1 (C), 128.8 (CH), 129.3 (CH), 157.9 (C), 
163.5 (C), 163.7 (C). HRMS (ESI-TOF) calcd. for C16H22N3O4: 320.1605 
[M+H]+; found: 320.1601. 
N-tert-Butyl-N-(2-fluorobenzyl)-α-(methoxycarbonyl)- α-
diazoacetamide (4j). 4j was obtained as a yellow oil that solidified on 
refrigeration (563 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1 equiv.), Et3N (1 equiv.), 84%; (b) p-ABSA (1.1 equiv.), 
DBU (1.5 equiv.), 56%]. 1H NMR (CDCl3, 400 MHz) δ 1.37 (s, 9H), 3.78 
(s, 3H), 4.67 (s, 2H), 7.00-7.14 (m, 2H) 7.22-7.29 (m, 2H). 13C NMR 
(CDCl3, 100.6 MHz) δ 28.8 (3 CH3), 46.2 (d, J = 3.4 Hz, CH2), 52.3 (CH3), 
58.9 (C), 68.2 (C), 116.0 (d, J = 21.7 Hz, CH), 124.3 (d, J = 3.7 Hz, CH), 
126.4 (d, J = 13.4 Hz, C), 129.3 (d, J = 8.2 Hz, CH), 129.5 (d, J = 4.3 Hz, 
CH), 160.8 (d, J = 246.5 Hz, C), 163.1 (C), 163.6 (C). HRMS (ESI-TOF) 
calcd. for C15H18FN3NaO3: 330.1224 [M+H]
+; found: 330.1225. 
N-(2-Bromobenzyl)-N-tert-butyl-α-(methoxycarbonyl)- α-
diazoacetamide (4k). 4k was obtained as a yellow oil that solidified on 
refrigeration (417 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1 equiv.), Et3N (1 equiv.); (b) p-ABSA (1.1 equiv.), 
DBU (1.5 equiv.), 83% two steps]. 1H NMR (CDCl3, 400 MHz) δ 1.42 (s, 
9H), 3.76 (s, 3H), 4.72 (s, 2H), 7.13 (ddd, J = 8.0, 7.6 and 2.4 Hz, 1H), 
7.26-7.34 (m, 2H), 7.54 (dd, J = 8.0 and 1.2 Hz, 1H). 13C NMR (CDCl3, 
100.6 MHz) δ 28.9 (3 CH3), 51.6 (CH2), 52.4 (CH3), 59.4 (C), 67.6 (C), 
122.1 (C), 127.5 (CH), 128.6 (CH), 128.9 (CH), 133.4 (CH), 138.5 (C), 
163.2 (C), 163.6 (C). HRMS (ESI-TOF) calcd. for C15H18BrN3NaO3: 
390.0424 [M+H]+; found: 390.0432. 
N-tert-Butyl-N-(2-iodobenzyl)-α-(methoxycarbonyl)- α-
diazoacetamide (4l). 4l was obtained as a yellow oil that solidified on 
refrigeration (260 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1.3 equiv.), Et3N (1.3 equiv.), 64%; (b) p-ABSA (1.1 
equiv.), DBU (1.5 equiv.), 89%]. 1H NMR (CDCl3, 400 MHz) δ 1.42 (s, 
9H), 3.76 (s, 3H), 4.63 (s, 2H), 6.97 (ddd, J = 8.0, 7.6 and 1.6 Hz, 1H), 
7.24 (dd, J = 7.6 and 1.6 Hz, 1H), 7.35 (td, J = 7.6 and 1.6 Hz, 1H), 7.83 
(dd, J = 8.0 and 1.6 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz) δ 29.0 (3 
CH3), 52.4 (CH3), 56.7 (CH2), 59.6 (C), 67.6 (C), 97.1 (C), 127.9 (CH), 
128.4 (CH), 129.1 (CH), 140.0 (CH), 141.2 (C), 163.2 (C), 163.5 (C). 




diazoacetamide (4m). 4m was obtained as a yellow oil that solidified on 
refrigeration (570 mg) following the procedures described above [(a) 
ClCOCH2CO2Me (1.2 equiv.), Et3N (1.2 equiv.), 68%; (b) p-ABSA (1.1 
equiv.), DBU (1.5 equiv.), 80%]. 1H NMR (CDCl3, 400 MHz) δ 1.40 (s, 
9H), 3.78 (s, 3H), 3.85 (s, 3H), 3.87 (s, 3H), 4.56 (s, 2H), 6.68 (d, J = 2.0 
Hz, 1H), 6.74 (dd, J = 8.4 and 2.0 Hz, 1H), 6.82 (d, J = 8.4 Hz, 1H). 13C 
NMR (CDCl3, 100.6 MHz) δ 28.9 (3 CH3), 51.3 (CH2), 52.3 (CH3), 56.0 
(CH3), 56.1 (CH3), 59.1 (C), 67.9 (C), 110.0 (CH), 111.4 (CH), 119.0 (CH), 
132.1 (C), 148.4 (C), 149.2 (C), 163.2 (2 C). HRMS (ESI-TOF) calcd. for 
C17H24N3O5: 350.1710 [M+H]
+; found: 350.1713. 
N-tert-Butyl-N-(1-phenylethyl)-α-(methoxycarbonyl)-α-
diazoacetamide (7). 7 was obtained as a yellow oil (210 mg) following 
the procedures described above [(a) ClCOCH2CO2Me (1.3 equiv.), Et3N 
(1.3 equiv.), 35%; (b) p-ABSA (1.1 equiv.), DBU (1.5 equiv.), 63%]. 1H 
NMR (CDCl3, 400 MHz) δ 1.46 (s, 9H), 1.80 (d, J = 7.2 Hz, 3H), 3.70 (s, 
3H), 5.19 (q, J = 7.2 Hz, 1H), 7.22-7.28 (m, 1H), 7.32-7.37 (m, 4H). 13C 
NMR (CDCl3, 100.6 MHz) δ 20.2 (CH3), 29.5 (3 CH3), 52.3 (CH3), 56.3 
(CH), 60.1 (C), 66.8 (C), 126.9 (2 CH), 127.2 (CH), 128.6 (2 CH), 142.3 
(C), 163.2 (C), 164.2 (C). HRMS (ESI-TOF) calcd. for C16H21N3NaO3: 
326.1475 [M+H]+; found: 326.1471. 
Representative Procedure for the Pd-Catalyzed Cyclisation 
Reactions (Table 2, Entry 3). A mixture of diazoamide 4a (50 mg, 0.17 
mmol), [Pd(allyl)Cl]2 (3 mg, 0.008 mmol) in dichloroethane (10 mL) was 
stirred at reflux under Argon atmosphere for 24 h. The solvent was 






removed in vacuo, and the residue was purified by chromatography (SiO2, 
from hexanes to hexanes-EtOAc 2:3) to give β-lactam trans-6a (29.5 mg, 
65%) and β-lactam cis-6a (11 mg, 25%). 
Methyl 2-benzyl-3-oxo-1H-2,3-dihydrocyclohepta[c]pyrrole-3a-
carboxylate (2). 25 mg (55%, Table 1, Entry 5). Brown oil. 1H NMR 
(CDCl3, 400 MHz) δ 3.61 (s, 3H), 4.01 (dd, J = 14.8 and 1.6 Hz, 1H), 4.27 
(dd, J = 14.8 and 2.4 Hz, 1H), 4.53 (d, J = 14.8 Hz, 1H), 4.69 (d, J = 14.8 
Hz, 1H), 5.65 (d, J = 9.6 Hz, 1H), 6.24 (m, 1H), 6.42-6.54 (m, 3H), 7.23-
7.36 (m, 5H). 13C NMR (CDCl3, 100.6 MHz) δ 47.0 (CH2), 50.3 (CH2), 
53.0 (CH3), 60.0 (C), 120.9 (CH), 122.4 (CH), 128.0 (CH), 128.1 (2 CH), 
128.3 (CH), 128.7 (CH), 129.0 (2 CH), 130.0 (CH), 130.4 (C), 135.6 (C), 
168.6 (C), 171.1 (C). HRMS (ESI-TOF) calcd. for C18H18NO3: 296.1281 
[M+H]+; found: 296.1281. 
Methyl cis-1-benzyl-2-oxo-4-phenylazetidine-3-carboxylate (cis-3). 
This compound could not be isolated and characterized. 1H NMR (CDCl3, 
400 MHz, significant signals from the crude reaction mixture) δ 3.33 (s, 
3H), 3.93 (d, J = 14.8 Hz, 1H), 4.34 (d, J = 6.0 Hz, 1H), 4.71 (dd, J = 6.0 
and 1.2 Hz, 1H), 4.94 (d, J = 14.8 Hz, 1H). 
Methyl trans-1-benzyl-2-oxo-4-phenylazetidine-3-carboxylate (trans-
3). 10.5 mg (23%, Table 1, Entry 7). Yellow gum. 1H NMR (CDCl3, 400 
MHz) δ 3.79 (s, 3H), 3.84 (d, J = 15.2 Hz, 1H), 3.93 (dd, J = 2.0 and 0.8 
Hz, 1H), 4.71 (d, J = 2.0 Hz, 1H), 4.85 (d, J = 15.2 Hz, 1H), 7.14-7.17 (m, 
2H), 7.23-7.40 (m, 8H). 13C NMR (CDCl3, 100.6 MHz) δ 45.1 (CH2), 52.9 
(CH3), 57.2 (CH), 63.4 (CH), 126.9 (2 CH), 128.0 (CH), 128.5 (2 CH), 
129.0 (2 CH), 129.2 (CH), 129.3 (2 CH), 134.8 (C), 136.0 (C), 162.4 (C), 




orange solid. 1H NMR (CDCl3, 400 MHz) δ 3.85 (s, 3H), 4.34 (d, J = 14.8 
Hz, 1H), 4.45 (d, J = 17.2 Hz, 1H), 4.62 (d, J = 17.2 Hz, 1H), 4.88 (d, J = 
14.8 Hz, 1H), 5.13 (s, 1H), 7.18-7.23 (m, 4H), 7.28-7.43 (m, 5H). 13C 
NMR (CDCl3, 100.6 MHz) δ 48.9 (CH2), 50.6 (CH2), 54.0 (CH), 54.5 
(CH3), 126.7 (2 CH), 128.0 (CH), 128.3 (CH), 128.4 (2 CH), 129.0 (2 CH), 
129.3 (2 CH), 132.3 (C), 136.2 (C), 165.5 (C), 165.6 (C). HRMS (ESI-
TOF) calcd. for C18H19ClNO3: 332.1048 [M+H]
+; found: 332.1049. 
Methyl 2-tert-butyl-3-oxo-1H-2,3-dihydrocyclohepta[c]pyrrole-3a-
carboxylate (5a). 1H NMR (CDCl3, 400 MHz, signals from a 8:1 mixture 
of 5a and trans-6a) δ 1.46 (s, 9H), 3.59 (s, 3H), 4.24 (dd, J = 15.2 and 
1.6 Hz, 1H), 4.47 (dd, J = 15.2 and 2.0 Hz, 1H), 5.59 (dd, J = 9.2 and 0.8 
Hz, 1H), 6.28 (m, 1H), 6.38-6.46 (m, 3H). 13C NMR (CDCl3, 100.6 MHz, 
signals from a 8:1 mixture of 5a and trans-6a) δ 27.6 (3 CH3), 49.6 (CH2), 
52.8 (CH3), 55.0 (C), 61.3 (C), 120.5 (CH), 123.2 (CH), 127.8 (CH), 128.9 
(CH), 129.9 (CH), 131.3 (C), 169.0 (C), 170.8 (C). 
Methyl cis-1-tert-butyl-2-oxo-4-phenylazetidine-3-carboxylate (cis-
6a). 11 mg (25%, Table 2, Entry 3). Yellow gum. 1H NMR (CDCl3, 400 
MHz) δ 1.31 (s, 9H), 3.32 (s, 3H), 4.23 (d, J = 6.4 Hz, 1H), 4.91 (d, J = 
6.4 Hz, 1H), 7.28-7.40 (m, 5H). 13C NMR (CDCl3, 100.6 MHz) δ 28.3 (3 
CH3), 52.0 (CH3), 55.2 (C), 56.8 (CH), 59.3 (CH), 127.2 (CH), 128.6 (2 
CH), 128.9 (2 CH), 136.7 (C), 163.0 (C), 166.6 (C). ). HRMS (ESI-TOF) 
calcd. for C15H20NO3: 262.1438 [M+H]
+; found: 262.1439. 
Methyl trans-1-tert-butyl-2-oxo-4-phenylazetidine-3-carboxylate 
(trans-6a). 29 mg (65%, Table 2, Entry 3). Amorphous white solid. 1H 
NMR (CDCl3, 400 MHz) δ 1.27 (s, 9H), 3.72 (d, J = 2.0 Hz, 1H), 3.78 (s, 
3H), 4.86 (d, J = 2.0 Hz, 1H), 7.31-7.42 (m, 5H). 13C NMR (CDCl3, 100.6 
MHz) δ 28.3 (3 CH3), 52.8 (CH3), 55.4 (C), 56.6 (CH), 62.5 (CH), 126.8 (2 
CH), 128.9 (CH), 129.2 (2 CH), 139.2 (C), 162.1 (C), 167.7 (C). HRMS 
(ESI-TOF) calcd. for C15H20NO3: 262.1438 [M+H]
+; found: 262.1439. 
Methyl 2-tert-butyl-6-methoxy-3-oxo-1H-2,3-
dihydrocyclohepta[c]pyrrole-3a-carboxylate (5b). 1H NMR (CDCl3, 
400 MHz, signals from a 10:1 mixture of 5b and trans-6b) δ 1.45 (s, 9H), 
3.60 (s, 3H), 3.61 (s, 3H), 4.18 (ddd, J = 14.4, 2.0 and 0.8 Hz, 1H), 4.42 
(ddd, J = 14.4, 2.4 and 1.2 Hz, 1H), 5.63 (dd, J = 7.2 and 1.6 Hz, 1H), 
5.73 (d, J = 10.8 Hz, 1H), 6.15 (dt, J = 7.2 and 2.0 Hz, 1H), 6.26 (dd, J = 
10.8 and 2.4 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz, signals from a 10:1 
mixture of 5b and trans-6b) δ 27.6 (3 CH3), 49.5 (CH2), 52.9 (CH3), 54.9 
(C), 55.0 (CH3), 60.8 (C), 101.8 (CH), 118.8 (CH), 124.9 (CH), 125.1 (C), 
126.2 (CH), 159.0 (C), 169.3 (C), 170.7 (C). 
Methyl cis-1-tert-butyl-4-(4-methoxyphenyl)-2-oxoazetidine-3-
carboxylate (cis-6b). 8 mg (18%, Table S1, Entry 1). Amorphous white 
solid. 1H NMR (CDCl3, 400 MHz) δ 1.30 (s, 9H), 3.38 (s, 3H), 3.80 (s, 3H), 
4.20 (d, J = 6.4 Hz, 1H), 4.87 (d, J = 6.4 Hz, 1H), 6.86 (d, J= 8.4 Hz, 2H), 
7.29 (d, J= 8.4 Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.3 (3 CH3), 
52.0 (CH3), 55.1 (C), 55.4 (CH3), 56.4 (CH), 59.3 (CH), 113.9 (2 CH), 
128.4 (2 CH), 128.5 (C), 160.0 (C), 163.1 (C), 166.8 (C). HRMS (ESI-
TOF) calcd. for C16H22NO4: 292.1543 [M+H]
+; found: 292.1549. 
Methyl trans-1-tert-butyl-4-(4-methoxyphenyl)-2-oxoazetidine-3-
carboxylate (trans-6b). 18 mg (39%, Table S1, Entry 1). Amorphous 
yellow solid. 1H NMR (CDCl3, 400 MHz) δ 1.26 (s, 9H), 3.69 (d, J = 2.0 
Hz, 1H), 3.77 (s, 3H), 3.82 (s, 3H), 4.81 (d, J = 2.0 Hz, 1H), 6.90 (d, J= 
8.4 Hz, 2H), 7.30 (d, J= 8.4 Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.3 
(3 CH3), 52.8 (CH3), 55.3 (C), 55.5 (CH3), 56.3 (CH), 62.5 (CH), 114.5 (2 
CH), 128.1 (2 CH), 131.0 (C), 160.1 (C), 162.2 (C), 167.9 (C). HRMS 
(ESI-TOF) calcd. for C16H22NO4: 292.1543 [M+H]
+; found: 292.1547. 
Methyl 2-tert-butyl-6-(methylthio)-3-oxo-1H-2,3-
dihydrocyclohepta[c]pyrrole-3a-carboxylate (5c). 1H NMR (CDCl3, 
400 MHz, signals from a 3.3:1 mixture of trans-6c and 5c) δ 1.45 (s, 9H), 
2.32 (s, 3H), 3.61 (s, 3H), 4.21 (d, J = 14.8 Hz, 1H), 4.43 (d, J = 14.8 Hz, 
1H), 5.64 (d, J = 10.4 Hz, 1H), 6.14 (d, J = 6.8 Hz, 1H), 6.38 (d, J = 10.8 
Hz, 1H), 6.39 (d, J = 6.8 Hz, 1H). 
Methyl cis-1-tert-butyl-4-[4-(methylthio)phenyl]-2-oxoazetidine-3-
carboxylate (cis-6c). 4.5 mg (10%, Table S1, Entry 3). Yellow gum. 1H 
NMR (CDCl3, 400 MHz) δ 1.30 (s, 9H), 2.48 (s, 3H), 3.37 (s, 3H), 4.22 (d, 
J = 6.4 Hz, 1H), 4.87 (d, J = 6.4 Hz, 1H), 7.20 (d, J= 8.4 Hz, 2H), 7.29 (d, 
J= 8.4 Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 15.6 (CH3), 28.3 (3 CH3), 
52.1 (CH3), 55.2 (C), 56.4 (CH), 59.2 (CH), 126.1 (2 CH), 127.7 (2 CH), 
133.2 (C), 139.6 (C), 163.0 (C), 166.6 (C). HRMS (ESI-TOF) calcd. for 
C16H22NO3S: 308.1315 [M+H]
+; found: 308.1319. 
Methyl trans-1-tert-butyl-4-[4-(methylthio)phenyl]-2-oxoazetidine-3-
carboxylate (trans-6c). 22 mg (48%, Table S1, Entry 3). Colourless oil. 
1H NMR (CDCl3, 400 MHz) δ 1.26 (s, 9H), 2.49 (s, 3H), 3.68 (d, J = 2.0 
Hz, 1H), 3.77 (s, 3H), 4.82 (d, J = 2.0 Hz, 1H), 7.24 (d, J= 8.0 Hz, 2H), 
7.30 (d, J= 8.0 Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 15.7 (CH3), 28.3 
(3 CH3), 52.8 (CH3), 55.4 (C), 56.3 (CH), 62.4 (CH), 126.8 (2 CH), 127.3 
(2 CH), 135.8 (C), 139.7 (C), 162.1 (C), 167.7 (C). HRMS (ESI-TOF) 
calcd. for C16H22NO3S: 308.1315 [M+H]
+; found: 308.1318. 
Methyl cis-1-tert-butyl-4-(4-chlorophenyl)-2-oxoazetidine-3-
carboxylate (cis-6d). 19 mg (42%, Table S1, Entry 5). Amorphous white 
solid. 1H NMR (CDCl3, 400 MHz) δ 1.30 (s, 9H), 3.38 (s, 3H), 4.23 (d, J = 
6.4 Hz, 1H), 4.89 (d, J = 6.4 Hz, 1H), 7.33 (s, 4H). 13C NMR (CDCl3, 
100.6 MHz) δ 28.3 (3 CH3), 52.2 (CH3), 55.3 (C), 56.1 (CH), 59.2 (CH), 
128.6 (2 CH), 128.8 (2 CH), 134.8 (C), 135.4 (C), 162.8 (C), 166.4 (C). 










carboxylate (trans-6d). 18 mg (40%, Table S1, Entry 5). Amorphous 
white solid. 1H NMR (CDCl3, 400 MHz) δ 1.26 (s, 9H), 3.67 (d, J = 2.0 Hz, 
1H), 3.78 (s, 3H), 4.84 (d, J = 2.0 Hz, 1H), 7.32-7-38 (m, 4H). 13C NMR 
(CDCl3, 100.6 MHz) δ 28.3 (3 CH3), 52.9 (CH3), 55.5 (C), 55.9 (CH), 62.5 
(CH), 128.1 (2 CH), 129.4 (2 CH), 134.8 (C), 137.9 (C), 162.0 (C), 167.4 




carboxylate (cis-6e). 12 mg (27%, Table S1, Entry 8). Yellow gum. 1H 
NMR (CDCl3, 400 MHz) δ 1.30 (s, 9H), 3.34 (s, 3H), 4.28 (d, J = 6.4 Hz, 
1H), 4.94 (d, J = 6.4 Hz, 1H), 7.52 (d, J= 8.4 Hz, 2H), 7.65 (d, J= 8.4 Hz, 
2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.3 (3 CH3), 52.2 (CH3), 55.5 (C), 
56.0 (CH), 59.2 (CH), 112.9 (C), 118.4 (C), 128.0 (2 CH), 132.4 (2 CH), 
142.5 (C), 162.5 (C), 166.0 (C). HRMS (ESI-TOF) calcd. for C16H19N2O3: 
287.1390 [M+H]+; found: 287.1389. 
Methyl trans-1-tert-butyl-4-(4-cyanophenyl)-2-oxoazetidine-3-
carboxylate (trans-6e). 23 mg (51%, Table S1, Entry 8). Amorphous 
white solid. 1H NMR (CDCl3, 400 MHz) δ 1.27 (s, 9H), 3.67 (d, J = 2.4 Hz, 
1H), 3.79 (s, 3H), 4.92 (d, J = 2.4 Hz, 1H), 7.53 (d, J= 8.4 Hz, 2H), 7.69 
(d, J= 8.4 Hz, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.3 (3 CH3), 53.1 
(CH3), 55.7 (C), 55.8 (CH), 62.5 (CH), 113.0 (C), 118.3 (C), 127.5 (2 CH), 
133.1 (2 CH), 144.9 (C), 161.7 (C), 167.0 (C). HRMS (ESI-TOF) calcd. 
for C16H19N2O3: 287.1390 [M+H]
+; found: 287.1393. 
Methyl trans-1-tert-butyl-4-[4-(dimethylamino)phenyl]-2-
oxoazetidine-3-carboxylate (trans-6f). 6 mg (14%, Table S1, Entry 9). 
Orange oil. 1H NMR (CDCl3, 400 MHz) δ 1.26 (s, 9H), 2.96 (s, 6H), 3.70 
(d, J = 2.0 Hz, 1H), 3.76 (s, 3H), 4.77 (d, J = 2.0 Hz, 1H), 6.69 (d, J= 8.8 
Hz, 2H), 7.23 (d, J= 8.8 Hz, 2H). HRMS (ESI-TOF) calcd. for C17H25N2O3: 
305.1860 [M+H]+; found: 305.1860. 
Methyl cis-1-tert-butyl-4-(3-chlorophenyl)-2-oxoazetidine-3-
carboxylate (cis-6g). 20 mg (44%, Table S1, Entry 11). Yellow gum. 1H 
NMR (CDCl3, 400 MHz) δ 1.31 (s, 9H), 3.40 (s, 3H), 4.24 (d, J = 6.4 Hz, 
1H), 4.87 (d, J = 6.4 Hz, 1H), 7.26-7.32 (m, 3H), 7.39 (d, J= 1.6 Hz, 1H). 
13C NMR (CDCl3, 100.6 MHz) δ 28.3 (3 CH3), 52.1 (CH3), 55.4 (C), 56.1 
(CH), 59.3 (CH), 125.4 (broad CH), 127.4 (broad CH), 129.1 (CH), 129.9 
(CH), 134.6 (C), 139.0 (C), 162.8 (C), 166.3 (C). HRMS (ESI-TOF) calcd. 
for C15H19ClNO3: 296.1048 [M+H]
+; found: 296.1057. 
Methyl trans-1-tert-butyl-4-(3-chlorophenyl)-2-oxoazetidine-3-
carboxylate (trans-6g). 16.5 mg (36%, Table S1, Entry 11). Brown gum. 
1H NMR (CDCl3, 400 MHz) δ 1.28 (s, 9H), 3.68 (d, J = 2.0 Hz, 1H), 3.78 
(s, 3H), 4.83 (d, J = 2.0 Hz, 1H), 7.27-7.34 (m, 3H), 7.39 (broad singlet, 
1H). 13C NMR (CDCl3, 100.6 MHz) δ 28.3 (3 CH3), 52.9 (CH3), 55.6 (C), 
55.9 (CH), 62.5 (CH), 124.8 (CH), 127.0 (CH), 129.2 (CH), 130.5 (CH), 
135.2 (C), 141.5 (C), 161.9 (C), 167.3 (C). HRMS (ESI-TOF) calcd. for 
C15H19ClNO3: 296.1048 [M+H]
+; found: 296.1050. 
Methyl cis-1-tert-butyl-4-(3-cyanophenyl)-2-oxoazetidine-3-
carboxylate (cis-6h). 10 mg (22%, Table S1, Entry 13). Colourless oil. 
1H NMR (CDCl3, 400 MHz) δ 1.31 (s, 9H), 3.38 (s, 3H), 4.28 (d, J = 6.4 
Hz, 1H), 4.93 (d, J = 6.4 Hz, 1H), 7.50 (dd, J= 8.4 and 7.6 Hz, 1H), 7.64 
(dt, J= 7.6 and 1.6 Hz, 1H), 7.65-7.70 (m, 2H). 13C NMR (CDCl3, 100.6 
MHz) δ 28.3 (3 CH3), 52.3 (CH3), 55.5 (C), 55.7 (CH), 59.3 (CH), 112.9 
(C), 118.4 (C), 129.5 (CH), 130.9 (broad, CH), 131.5 (broad, CH), 132.6 
(CH), 138.8 (C), 162.5 (C), 166.1 (C). HRMS (ESI-TOF) calcd. for 
C16H19N2O3: 287.1390 [M+H]
+; found: 287.1399. 
Methyl trans-1-tert-butyl-4-(3-cyanophenyl)-2-oxoazetidine-3-
carboxylate (trans-6h). 19.5 mg (43%, Table S1, Entry 13). Amorphous 
yellow solid. 1H NMR (CDCl3, 400 MHz) δ 1.28 (s, 9H), 3.68 (d, J = 2.4 
Hz, 1H), 3.80 (s, 3H), 4.91 (d, J = 2.4 Hz, 1H), 7.54 (td, J= 7.6 and 0.4 Hz, 
1H), 7.64-7.71 (m, 3H). 13C NMR (CDCl3, 100.6 MHz) δ 28.3 (3 CH3), 
53.0 (CH3), 55.5 (CH), 55.7 (C), 62.5 (CH), 113.5 (C), 118.3 (C), 130.2 
(CH), 130.4 (CH), 130.8 (CH), 132.6 (CH), 141.2 (C), 161.7 (C), 167.0 




carboxylate (cis-6i). 5 mg (10%, Table S1, Entry 16). Yellow gum. 1H 
NMR (CDCl3, 400 MHz) δ 1.33 (s, 9H), 3.29 (s, 3H), 3.85 (s, 3H), 4.22 (d, 
J = 6.4 Hz, 1H), 5.43 (d, J = 6.4 Hz, 1H), 6.85 (d, J= 8.0 Hz, 1H), 6.94 
(ddd, J= 8.0, 7.6 and 0.8 Hz, 1H), 7.26 (dd, J = 8.0 and 7.6 Hz, 1H), 7.44 
(d, J = 8.8 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz, signals from a 1:8 
mixture of 5i and cis-6i) δ 28.1 (3 CH3), 50.0 (CH), 51.8 (CH3), 54.9 (C), 
55.8 (CH3), 58.7 (CH), 110.6 (CH), 120.2 (CH), 124.8 (C), 127.5 (CH), 
129.6 (CH), 157.3 (C), 163.8 (C), 166.8 (C). 
Methyl trans-1-tert-butyl-4-(2-methoxyphenyl)-2-oxoazetidine-3-
carboxylate (trans-6i). 29 mg (63%, Table S1, Entry 16). Amorphous 
orange solid. 1H NMR (CDCl3, 400 MHz) δ 1.26 (s, 9H), 3.78 (s, 3H), 
3.84 (s, 3H), 3.86 (broad, 1H), 5.17 (d, J = 2.0 Hz, 1H), 6.89 (dd, J= 8.0 
and 1.2 Hz, 1H), 6.96 (td, J= 7.6 and 1.2 Hz, 1H), 7.30 (ddd, J= 8.0, 7.6 
and 2.0 Hz, 1H), 7.35 (dd, J= 7.6 and 2.0 Hz, 1H). 13C NMR (CDCl3, 
100.6 MHz) δ 28.0 (3 CH3), 52.2 (broad, CH), 52.7 (CH3), 55.0 (C), 55.5 
(CH3), 60.4 (CH), 111.0 (CH), 120.9 (CH), 126.5 (C), 128.5 (broad, CH), 
129.9 (CH), 157.7 (C), 162.5 (C), 168.4 (C). HRMS (ESI-TOF) calcd. for 
C16H22NO4: 292.1543 [M+H]
+; found: 292.1539. 
Methyl cis-1-tert-butyl-4-(2-fluorophenyl)-2-oxoazetidine-3-
carboxylate (cis-6j). 1H NMR (CDCl3, 400 MHz, signals from a 8:1 
mixture of cis-6j and trans-6j) δ 1.32 (s, 9H), 3.36 (broad s, 3H), 4.28 (d, 
J = 6.4 Hz, 1H), 5.30 (broad, 1H), 7.05 (ddd, J= 10.4, 8.0 and 1.2 Hz, 1H), 
7.15 (td, J= 7.6 and 1.2 Hz, 1H), 7.27-7.33 (m, 1H), 7.49 (ddd, J= 8.0, 7.6 
and 1.2 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz, signals from a 8:1 mixture 
of cis-6j and trans-6j) δ 28.1 (3 CH3), 52.1 (CH3), 55.2 (C), 58.5 (broad, 
CH), 61.1 (broad, CH), 115.7 (d, J = 21.5 Hz, CH), 124.0 (d, J = 12.0 Hz, 
CH), 124.0 (d, J= 3.6 Hz, CH), 128.0 (broad, C), 130.4 (d, J = 8.3 Hz, 
CH), 163.0 (C), 166.4 (C). One C was not observed. 
Methyl trans-1-tert-butyl-4-(2-fluorophenyl)-2-oxoazetidine-3-
carboxylate (trans-6j). 30 mg (66%, Table S1, Entry 18). Amorphous 
white solid. 1H NMR (CDCl3, 400 MHz) δ 1.27 (s, 9H), 3.79 (s, 3H), 3.84 
(d, J = 2.4 Hz, 1H), 5.16 (d, J = 2.4 Hz, 1H), 7.08 (ddd, J= 10.4, 8.0 and 
1.2 Hz, 1H), 7.18 (td, J= 7.6 and 1.2 Hz, 1H), 7.30-7.36 (m, 1H), 7.43 (td, 
J= 7.6 and 1.2 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz) δ 28.0 (3 CH3), 
50.3 (d, J = 3.8 Hz, CH), 52.9 (CH3), 55.3 (C), 61.1 (d, J = 1.8 Hz, CH), 
116.3 (d, J = 21.5 Hz, CH), 124.8 (d, J = 3.6 Hz, CH), 126.0 (d, J = 11.9 
Hz, C), 128.5 (d, J= 3.6 Hz, CH), 130.6 (d, J = 8.4 Hz, CH), 160.9 (d, J = 
248.7 Hz, C), 161.9 (C), 167.6 (C). HRMS (ESI-TOF) calcd. for 
C15H19FNO3: 280.1343 [M+H]
+; found: 280.1345. 
Methyl 2-tert-butyl-8-bromo-3-oxo-1H-2,3-
dihydrocyclohepta[c]pyrrole-3a-carboxylate (5k). 1H NMR (CDCl3, 
400 MHz, signals from a 1:2 mixture of 5k and trans-6k) δ 1.48 (s, 9H), 
3.61 (s, 3H), 4.15 (d, J = 16.0 Hz, 1H), 4.28 (d, J = 16.0 Hz, 1H), 5.65-
5.69 (m, 1H), 6.36-6.43 (m, 2H), 6.50-6.57 (m, 1H). 







carboxylate (cis-6k). 16 mg (34%, Table S1, Entry 19). Amorphous 
orange solid. 1H NMR (CDCl3, 400 MHz) δ 1.34 (s, 9H), 3.31 (s, 3H), 
4.31 (d, J = 6.4 Hz, 1H), 5.39 (d, J = 6.4 Hz, 1H), 7.18 (ddd, J= 8.0, 7.2 
and 1.6 Hz, 1H), 7.33 (ddd, J= 7.6, 7.2 and 1.2 Hz, 1H), 7.53-7.57 (m, 
2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.1 (3 CH3), 52.0 (CH3), 55.2 (C), 
55.5 (CH), 58.4 (CH), 123.4 (C), 127.2 (CH), 128.5 (CH), 130.0 (CH), 
133.0 (CH), 135.7 (C), 163.3 (C), 166.2 (C). HRMS (ESI-TOF) calcd. for 
C15H19BrNO3: 340.0543 [M+H]
+; found: 340.0542. 
Methyl trans-4-(2-bromophenyl)-1-tert-butyl-2-oxoazetidine-3-
carboxylate (trans-6k). 14 mg (31%, Table S1, Entry 19). Amorphous 
yellow solid. 1H NMR (CDCl3, 400 MHz) δ 1.31 (s, 9H), 3.59 (broad, 1H), 
3.80 (s, 3H), 5.38 (broad, 1H), 7.19 (ddd, J= 8.0, 7.6 and 1.2 Hz, 1H), 
7.37 (ddd, J= 8.0, 7.6 and 1.2 Hz, 1H), 7.50 (dd, J = 8.0 and 1.2 Hz, 1H), 
7.57 (dd, J = 8.0 and 1.2 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz) δ 28.1 (3 
CH3), 52.9 (CH3), 55.2 (broad, CH), 55.4 (C), 62.1 (broad, CH), 127.2 
(broad, CH), 128.1 (CH), 128.5 (C), 130.1 (CH), 133.0 (C), 133.4 (broad, 
CH), 162.5 (C), 167.4 (C). HRMS (ESI-TOF) calcd. for C15H19BrNO3: 
340.0543 [M+H]+; found: 340.0552. 
Methyl 2-tert-butyl-8-iodo-3-oxo-1H-2,3-
dihydrocyclohepta[c]pyrrole-3a-carboxylate (5l). 1H NMR (CDCl3, 400 
MHz, signals from a 1:3.3 mixture of 5l and trans-6l) δ 1.49 (s, 9H), 3.60 
(s, 3H), 4.04 (d, J = 16.4 Hz, 1H), 4.22 (d, J = 16.4 Hz, 1H), 5.62 (d, J = 
10.0 Hz, 1H), 6.23 (dd, J = 11.6 and 6.0 Hz, 1H), 6.43 (dd, J = 10.0 and 
6.0 Hz, 1H), 6.72 (d, J = 11.6 Hz, 1H). 
Methyl cis-4-(2-iodophenyl)-1-tert-butyl-2-oxoazetidine-3-
carboxylate (cis-6l). 23 mg (49%, Table S1, Entry 21). Amorphous 
yellow solid. 1H NMR (CDCl3, 400 MHz) δ 1.33 (s, 9H), 3.30 (s, 3H), 4.31 
(d, J = 6.4 Hz, 1H), 5.22 (d, J = 6.4 Hz, 1H), 7.02 (ddd, J= 8.0, 7.2 and 
1.6 Hz, 1H), 7.36 (ddd, J= 8.0, 7.2 and 1.6 Hz, 1H), 7.52 (dd, J = 8.0 and 
1.6 Hz, 1H), 7.83 (dd, J = 8.0 and 1.6 Hz, 1H). 13C NMR (CDCl3, 100.6 
MHz) δ 28.2 (3 CH3), 52.0 (CH3), 55.3 (C), 58.4 (CH), 60.6 (CH), 98.7 (C), 
128.0 (CH), 128.2 (CH), 130.4 (CH), 138.5 (C), 139.7 (CH), 163.2 (C), 




carboxylate (trans-6l). 18 mg (38%, Table S1, Entry 21). Yellow gum. 
1H NMR (CDCl3, 400 MHz) δ 1.31 (s, 9H), 3.55 (d, J = 2.0 Hz, 1H), 3.81 
(s, 3H), 5.24 (d, J = 2.0 Hz, 1H), 7.03 (ddd, J= 8.0, 7.2 and 2.0 Hz, 1H), 
7.40 (ddd, J= 8.0, 7.2 and 1.2 Hz, 1H), 7.46 (dd, J = 8.0 and 2.0 Hz, 1H), 
7.85 (dd, J = 8.0 and 1.2 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz) δ 28.2 (3 
CH3), 52.9 (CH3), 55.5 (C), 60.3 (CH), 62.4 (CH), 98.4 (C), 126.9 (broad, 
CH), 128.9 (CH), 130.4 (CH), 140.0 (broad, CH), 141.4 (C), 162.5 (C), 




dihydrocyclohepta[c]pyrrole-3a-carboxylate (5m). 1H NMR (CDCl3, 
400 MHz, signals from a 1.5:1 mixture of 5m and trans-6m) δ 1.46 (s, 
9H), 3.61 (s, 3H), 3.67 (s, 3H), 3.73 (s, 3H), 4.21 (ddd, J = 14.4, 1.6 and 
0.8 Hz, 1H), 4.40 (ddd, J = 14.4, 2.4 and 1.2 Hz, 1H), 5.01 (s, 1H), 5.67 
(d, J = 7.2 Hz, 1H), 6.00 (ddd, J = 7.2, 2.4 and 0.8 Hz, 1H). 13C NMR 
(CDCl3, 100.6 MHz, signals from a 1.5:1 mixture of 5m and trans-6m) δ 
27.6 (3 CH3), 49.2 (CH2), 52.9 (CH3), 55.0 (C), 55.9 (CH3), 56.2 (CH3), 
57.9 (C), 99.8 (CH), 103.5 (CH), 117.3 (CH), 131.1 (C), 152.3 (C), 154.9 
(C), 169.9 (C), 171.1 (C). 
Methyl cis-1-tert-butyl-4-(3,4-dimethoxyphenyl)-2-oxoazetidine-3-
carboxylate (cis-6m). 3 mg (6%, Table S1, Entry 24). Yellow gum. 1H 
NMR (CDCl3, 400 MHz) δ 1.31 (s, 9H), 3.40 (s, 3H), 3.88 (s, 6H), 4.21 (d, 
J = 6.4 Hz, 1H), 4.86 (d, J = 6.4 Hz, 1H), 6.82 (d, J= 8.4 Hz, 1H), 6.91-
6.93 (m, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 28.3 (3 CH3), 52.2 (CH3), 
55.1 (C), 56.0 (CH3), 56.1 (CH3), 56.8 (CH), 59.3 (CH), 109.8 (broad, CH), 
110.9 (CH), 120.1 (broad, CH), 129.0 (C), 149.0 (C), 149.4 (C), 163.0 (C), 




carboxylate (trans-6m). 17.5 mg (38%, Table S1, Entry 24). Amorphous 
yellow solid. 1H NMR (CDCl3, 400 MHz) δ 1.28 (s, 9H), 3.71 (d, J = 2.4 
Hz, 1H), 3.78 (s, 3H), 3.89 (s, 6H), 4.82 (d, J = 2.4 Hz, 1H), 6.85 (d, J= 
8.0 Hz, 1H), 6.88 (d, J = 2.4 Hz, 1H), 6.95 (dd, J = 8.0 and 2.4 Hz, 1H). 
13C NMR (CDCl3, 100.6 MHz) δ 28.2 (3 CH3), 52.8 (CH3), 55.3 (C), 56.1 
(CH3), 56.2 (CH3), 56.6 (CH), 62.5 (CH), 109.1 (CH), 111.4 (CH), 119.6 
(CH), 131.4 (C), 149.5 (C), 149.6 (C), 162.2 (C), 167.8 (C). HRMS (ESI-
TOF) calcd. for C17H24NO5: 322.1654 [M+H]
+; found: 322.1655. 
Methyl 2-tert-butyl-1-methyl-3-oxo-1H-2,3-
dihydrocyclohepta[c]pyrrole-3a-carboxylate (8). 7 mg (15%, Table 3, 
Entry 1). 1H NMR (CDCl3, 400 MHz, signals from a 1:1.2 mixture of 
stereoisomers) δ 1.37 (d, J = 6.0 Hz, 3H minor isomer), 1.50 (s, 9H major 
isomer), 1.51 (s, 9H minor isomer), 1.72 (d, J = 6.0 Hz, 3H major isomer), 
3.55 (s, 3H minor isomer), 3.60 (s, 3H major isomer), 4.53 (qd, J = 6.0 
and 1.6 Hz, 1H major isomer), 4.75 (qd, J = 6.0 and 1.6 Hz, 1H minor 
isomer), 5.57 (d, J = 9.6 Hz, 1H major isomer), 5.65 (d, J = 9.6 Hz, 1H 
minor isomer), 6.23-6.28 (m, 1H major and 1H minor isomer), 6.35-6.53 
(m, 3H major and 3H minor isomer). 13C NMR (CDCl3, 100.6 MHz, 
signals from a 1:1.2 mixture of stereoisomers) δ 25.7 (CH3), 28.3 (CH3), 
28.4 (3 CH3), 29.4 (3 CH3), 52.8 (CH3), 52.9 (CH3), 55.3 (C), 55.4 (C), 
57.5 (CH), 57.6 (CH), 60.7 (C), 61.0 (C), 118.8 (CH), 119.8 (CH), 122.8 
(CH), 124.0 (CH), 127.7 (2 CH), 128.6 (CH), 128.9 (CH), 129.4 (CH), 
130.0 (CH), 138.4 (C), 138.6 (C), 168.9 (C), 169.0 (C), 170.1 (C), 170.7 
(C). 
Methyl (2RS,3RS)-1-(tert-butyl)-2-methyl-4-oxo-2-phenylazetidine-3-
carboxylate (9). 10.5 mg (23%, Table 3, Entry 3). Yellow gum. 1H NMR 
(CDCl3, 400 MHz) δ 1.38 (s, 9H), 2.11 (s, 3H), 3.23 (s, 3H), 3.84 (s, 1H), 
7.29-7.38 (m, 3H), 7.46-7.50 (m, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 
26.2 (CH3), 28.6 (3 CH3), 51.8 (CH3), 55.8 (C), 64.9 (C), 66.8 (CH), 126.6 
(2 CH), 128.3 (2 CH), 139.9 (C), 162.8 (C), 166.7 (C). One CH was not 




carboxylate (10). 21 mg (47%, Table 3, Entry 3). Amorphous orange 
solid. 1H NMR (CDCl3, 400 MHz) δ 1.31 (s, 9H), 1.96 (s, 3H), 3.75 (s, 3H), 
3.86 (s, 1H), 7.32 (ddd, J = 7.2, 6.0 and 1.2 Hz, 1H), 7.37-7.42 (m, 2H), 
7.47-7.51 (m, 2H). 13C NMR (CDCl3, 100.6 MHz) δ 20.7 (CH3), 28.6 (3 
CH3), 52.4 (CH3), 56.0 (C), 62.6 (C), 67.0 (CH), 125.5 (2 CH), 128.3 (CH), 
128.9 (2 CH), 143.3 (C), 162.9 (C), 167.3 (C). HRMS (ESI-TOF) calcd. 
for C16H22NO3: 276.1594 [M+H]
+; found: 276.1596. 
Computational Details. All the calculations reported in this paper were 
performed with the Gaussian 09 suite of programs.[20] Electron correlation 
was partially taken into account using the hybrid functional usually 
denoted as B3LYP[21] in conjunction with the D3 dispersion correction 
suggested by Grimme et al.[22] using the double-ζ quality plus polarization 
def2-SVP[23] basis set for all atoms. Reactants and products were 
characterized by frequency calculations,[24] and have positive definite 
Hessian matrices. Transition structures (TS’s) show only one negative 
eigenvalue in their diagonalized force constant matrices, and their 
associated eigenvectors were confirmed to correspond to the motion 
along the reaction coordinate under consideration using the Intrinsic 






Reaction Coordinate (IRC) method.[25] Solvents effects were also taken 
into account using the Polarizable Continuum Model (PCM)[26] during the 
geometry optimizations. This level is denoted PCM-(dichloroethane)-
B3LYP-D3/def2-SVP. Single-point energy refinements were carried out 
at the M06L[27]/def2-TZVPP[24] level of theory employing the PCM model 
to account for solvation. This level is denoted PCM(dichloroethane)-
M06L/def2-TZVP//PCM-(dichloroethane)-B3LYP-D3/def2-SVP. 
Acknowledgements 
We gratefully acknowledge financial support for this work from 
MINECO-FEDER (Projects CTQ2015-64937-R, CTQ2016-
78205-P and CTQ2016-81797-REDC). 
Keywords: palladium-catalysis • carbene insertion • diazo 
compounds • β-lactams • density functional theory calculations 
[1] For recent reviews, see: a) H. M. L. Davies, J. R. Manning, Nature 2008, 
451, 417-424; b) M. P. Doyle, R. Duffy, M. Ratnikov, L. Zhou, Chem. 
Rev. 2010, 110, 704-724; c) A. Ford, H. Miel, A. Ring, C. N. Slattery, A. 
R. Maguire, M. A. McKervey, Chem. Rev. 2015, 115, 9981-10080; d) F. 
J. Lombard, M. J. Coster, Org. Biomol. Chem. 2015, 13, 6419-6431. 
[2] See, for example: a) Y. Cai, S.-F. Zhu, G.-P. Wang, Q.-L. Zhou, Adv. 
Synth. Catal. 2011, 353, 2939-2944; b) T. Yao, K. Hirano, T. Satoh, M. 
Miura, Angew. Chem. Int. Ed. 2012, 51, 775-779; c) Z. Yu, B. Ma, M. 
Chen, H.-H. Wu, L. Liu, J. Zhang, J. Am. Chem. Soc. 2014, 136, 6904-
6907; d) M. R. Fructos, M. M. Díaz-Requejo, P. J. Pérez, Chem. 
Commun. 2016, 52, 7326-7335; e) L. Liu, J. Zhang, Chem. Soc. Rev. 
2016, 45, 506-516; f) A. Conde, G. Sabenya, M. Rodríguez, V. Postils, 
J. M. Luis, M. M. Díaz-Requejo, M. Costas, P. J. Pérez, Angew. Chem. 
Int. Ed. 2016, 55, 6530-6534. 
[3] H. M. L. Davies, B. T. Parr, in Contemporary Carbene Chemistry; 
Wiley: Hoboken, NJ, 2013, pp 363-403. 
[4] a) M. M. Díaz-Requejo, P. J. Pérez, Chem. Rev. 2008, 108, 3379-3394; 
b) X. Zhao, Y. Zhang, J. Wang, Chem. Commun. 2012, 48, 10162-
10173. 
[5] a) M. K-W. Choi, W.-Y. Yu, C.-M. Che, Org. Lett. 2005, 7, 1081-1084; 
b) M. K-W. Choi, W.-Y. Yu, M.-H. So, C.-Y. Zhou, Q.-H. Deng, C.-M. 
Che, Chem. Asian J. 2008, 3, 1256-1265; c) C. Y. Zhou, J. S. Huang, 
C.-M. Che, Synlett 2010, 2681-2700; d) A. R. Reddy, C.-Y. Zhou, Z. 
Guo, J. Wei, C.-M. Che, Angew. Chem. Int. Ed. 2014, 53, 14175-14180. 
[6] See, for example: a) D. F. Taber, J. C. Amedio Jr., R. G. Sherill, J. Org. 
Chem. 1986, 51, 3382-3384; b) M. Matsumoto, N. Watanabe, H. 
Kobayashi, Heterocycles 1987, 26, 1479-1482; c) M. L. Rosenberg, J. 
H. F. Aasheim, M. Trebbin, E. Uggerud, T. Hansen, Tetrahedron Lett. 
2009, 50, 6506-6509. 
[7] a) D. Solé, F. Mariani, M.-L. Bennasar, I. Fernández, Angew. Chem. Int. 
Ed. 2016, 55, 6467-6470; b) D. Solé, A. Amenta, F. Mariani, M.-L. 
Bennasar, I. Fernández, Adv. Synth. Catal. 2017, 359, 3654-3664. 
[8] D. Solé, F. Pérez-Janer, I. Fernández, Chem. Commun. 2017, 53, 
3110-3113. 
[9] For some reviews on the transition metal-catalyzed synthesis of β-
lactams, see: a) P. M. P. Gois, C. A. M. Afonso, Eur. J. Org. Chem. 
2004, 3773-3788; b) A. Ring, A. Ford, A. R. Maguire, Tetrahedron Lett. 
2016, 57, 5399-5406. 
[10] a) C. A. Merlic, A. L. Zechman, Synthesis 2003, 1137-1156; b) H. M. L. 
Davies, D. Morton, Chem. Soc. Rev. 2011, 40, 1857-1869; c) A. 
DeAngelis, R. Panish, J. M. Fox, Acc. Chem. Res. 2016, 49, 115-127. 
[11] For the use of other transition metals to promote the decomposition of 
this amide, see: a) Rhodium: S. Miah, A. M. Z. Slawin, C. J. Moody, S. 
M. Sheedan, J. P. Marino, M. A. Semones, A. Padwa, I. C. Richards, 
Tetrahedron 1996, 52, 2489-2514; b) Ruthenium: M. Grohmann, G. 
Maas, Tetrahedron 2007, 63, 12172-12178; c) Cupper: J. Liu, J. Tu, Z. 
Yang, C.-U. Pak, J. Xu, Tetrahedron 2017, 73, 4616-4626. 
[12] V. K.-Y. Lo, Z. Guo, M. K.-W. Choi, W.-Y. Yu, J.-S. Huang, C.-M. Che, J. 
Am. Chem. Soc. 2012, 134, 7588-7591. 
[13] A. Padwa, D. J. Austin, A. T. Price, M. A. Semones, M. P. Doyle, M. N. 
Protopopova, W. R. Winchester, A. Tran, J. Am. Chem. Soc. 1993, 115, 
8669-8680. 
[14] a) N. Watanabe, M. Anada, S.-H. Hashimoto, S. Ikegami, Synlett 1994, 
1031-1033; b) M. P. Doyle, R. J. Pieters, J. Taunton, H. Q. Pho, A. 
Padwa, D. L. Hertzog, L. Precedo, J. Org. Chem. 1991, 56, 820-829; c) 
C. H. Yoon, A. Nagle, C. Chen, D. Gandhi, K. W. Jung, Org. Lett. 2003, 
5, 2259-2262; d) Z. Chen, Z. Chen, Y. Jiang, W. Hu, Synlett 2004, 
1763-1764; e) A. G. H. Wee, S. C. Duncan, J. Org. Chem. 2005, 70, 
8372-8380. 
[15] For the use of other transition metals to promote the decomposition of 
this amide, see: a) Rhodium: N. R. Candeias, C. Carias, L. F. R. 
Gomes, V. André, M. T. Duarte, P. M. P. Gois, C. A. M. Afonso, Adv. 
Synth. Catal. 2012, 354, 2921-2927; b) Ruthenium: T. Large, T. Müller, 
H. Kunkel, S. Buck, G. Z. Maas, Naturforsch. B: J. Chem. Sci., 2012, 67, 
347-353. See also ref. 11b. 
[16] Following some literature precedents (see ref. 15a), the crude reaction 
mixture was filtered over a basic alumina pad to induce complete 
epimerization of β-lactam to the trans isomer before the 
chromatographic purification. However, this process resulted in the 
isolation of 5a and trans-6a in low yields. 
[17] E. Nakamura, N. Yoshikai, M. Yamanaka, J. Am. Chem. Soc. 2002, 
124, 7181-7192. 
[18] All calculations were carried out at the PCM(dichloroethane)-
M06L/def2-TZVPP//PCM(dichloroethane)-B3LYP-D3/def2-SVP level. 
See Computational Details. 
[19] The intermediacy of a zwitterionic species in these Pd-catalyzed 
insertions is experimentally supported by the isolation of 4-
(dimethylamino)benzaldehyde in the reactions of 4f. This aldehyde 
would be formed by hydrolysis of the corresponding zwitterionic 
intermediate. 
[20] Gaussian 09, Revision D.01, M. J. Frisch, G. W. Trucks, H. B. Schlegel, 
G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, 
B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. 
Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. 
Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. 
Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, 
Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. 
Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, 
A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. 
M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. 
Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. 
Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. 
Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. 
D. Daniels, Ö. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. 
J. Fox, Gaussian, Inc., Wallingford CT, 2009. 
[21] a) A. D. Becke, J. Chem. Phys. 1993, 98, 5648-5652; b) C. Lee, W. 
Yang, R. G. Parr, Phys. Rev. B 1998, 37, 785-789; c) S. H. Vosko, L. 
Wilk, M. Nusair, Can. J. Phys. 1980, 58, 1200-1211. 
[22] S. Grimme, J. Antony, S. Ehrlich, H. Krieg, J. Chem. Phys. 2010, 132, 
154104-154119. 
[23] a) A. Schäfer, H. Horn, R. Ahlrichs, J. Chem. Phys. 1992, 97, 2571-
2577; b) F. Weigend, R. Alhrichs, Phys. Chem. Chem. Phys. 2005, 7, 
3297-3305. 
[24] J. W. McIver, A. K. Komornicki, J. Am. Chem. Soc. 1972, 94, 2625-
2633. 
[25] C. González, H. B. Schlegel, J. Phys. Chem. 1990, 94, 5523-5527. 
[26] a) S. Miertuš, E. Scrocco, J. Tomasi, Chem. Phys. 1981, 55, 117-129; 
b) J. L. Pascual-Ahuir, E. Silla, I. Tuñón, J. Comp. Chem. 1994, 15, 






1127-1138; c) V. Barone, M. Cossi, J. Phys. Chem. A 1998, 102, 1995-
2001. 
[27] Y. Zhao, D. G. Truhlar, Acc. Chem. Res. 2008, 41, 157-167. 












The intramolecular carbene C–H 
insertion of α-diazo-α-
(methoxycarbonyl)acetamides leading 
to β-lactams is effectively catalyzed by 
Pd(II)-complexes. According to DFT 
calculations, this insertion reaction 
occurs stepwise through a 
metallacarbene-induced zwitterionic 
intermediate. 
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